Market Cap 3.20B
Revenue (ttm) 1.14M
Net Income (ttm) -88.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,722.81%
Debt to Equity Ratio 0.00
Volume 662,200
Avg Vol 951,136
Day's Range N/A - N/A
Shares Out 76.25M
Stochastic %K 68%
Beta 1.31
Analysts Strong Sell
Price Target $68.08

Company Profile

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003, which is in phase 3 clinical trial for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 that is in phase 2 clinical trial to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC p...

Industry: Biotechnology
Sector: Healthcare
Phone: 949 409 3700
Address:
400 Spectrum Center Drive, Suite 2040, Irvine, United States
pat_soons_shlong
pat_soons_shlong Oct. 23 at 6:02 PM
$CGON what do you guys think of the current valuation? I just closed out of my position for a 55% gain, but id like to understand your guys perspective This is not my main stock and I don’t have the time for an intricate deep dive on more than a couple of my positions
0 · Reply
Buy_SoFi
Buy_SoFi Oct. 23 at 5:04 PM
$TLTFF $MRK $IBRX $CGON Potential NASDAQ listing rumored/expected? ---> $TLTFF
0 · Reply
Buy_SoFi
Buy_SoFi Oct. 23 at 5:03 PM
$TLTFF $MRK $IBRX $CGON NMIBC Phase II study about to complete enrolment. AMAZING numbers! (Potential FDA Accelerated Approval) ---> $TLTFF
0 · Reply
Jarra123
Jarra123 Oct. 10 at 3:11 PM
$CGON new competitor approaching with completed phase two, fast track for neoadjuvant therapy https://hamletbiopharma.com/hamlet-biopharma-announces-the-completion-of-the-alpha1h-phase-ii-study-in-non-muscle-invasive-bladder-cancer/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 10:56 PM
9/26/25 list results $CGAU $CGEN $CGNX $CGON 🔥 Cycle Trading Signal plugged into AI 🔥 list
0 · Reply
dlhman2002
dlhman2002 Oct. 9 at 2:05 PM
$CGON More large buys coming in today.
1 · Reply
autopilotcopytrader
autopilotcopytrader Oct. 8 at 3:50 PM
$CGON bought this morning premarket sold the rip yay :-) may reenter
0 · Reply
JarvisFlow
JarvisFlow Oct. 8 at 12:47 PM
Guggenheim has updated their rating for CG Oncology ( $CGON ) to Buy with a price target of 90.
0 · Reply
Grinding10
Grinding10 Oct. 7 at 5:48 PM
$CGON is this BLA ever going to get fucking submitted or what?
1 · Reply
Buy_SoFi
Buy_SoFi Sep. 23 at 3:00 PM
$TLTFF Rutherin and Ruvidar are miracle compounds, making other compounds even more potent. Acquisition target in the coming 2-3 years, maybe sooner. $CGON $IBRX
0 · Reply
Latest News on CGON
CG Oncology Stock Signals Bullish Momentum Ahead

Sep 8, 2025, 9:08 AM EDT - 6 weeks ago

CG Oncology Stock Signals Bullish Momentum Ahead


CG Oncology Completes Enrollment in PIVOT-006

Sep 3, 2025, 8:00 AM EDT - 7 weeks ago

CG Oncology Completes Enrollment in PIVOT-006


CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why

Apr 28, 2025, 11:14 AM EDT - 6 months ago

CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why


CG Oncology Looks Attractive At Current Prices (Rating Upgrade)

Apr 2, 2025, 12:32 PM EDT - 7 months ago

CG Oncology Looks Attractive At Current Prices (Rating Upgrade)


CG Oncology Announces Pricing of Public Offering

Dec 12, 2024, 8:19 PM EST - 11 months ago

CG Oncology Announces Pricing of Public Offering


CG Oncology Announces Proposed Public Offering

Dec 11, 2024, 6:17 AM EST - 11 months ago

CG Oncology Announces Proposed Public Offering


CG Oncology: Promising Data, But Looks Expensive

Aug 26, 2024, 10:34 AM EDT - 1 year ago

CG Oncology: Promising Data, But Looks Expensive


Protara: A Bombed Out Biotech With A Very Positive Skew

Feb 22, 2024, 8:55 AM EST - 1 year ago

Protara: A Bombed Out Biotech With A Very Positive Skew

TARA


Biotech's First IPO of 2024 Popped 96%. What It Means.

Jan 26, 2024, 11:50 AM EST - 1 year ago

Biotech's First IPO of 2024 Popped 96%. What It Means.


CG Oncology valued at $1.75 bln in strong market debut

Jan 25, 2024, 1:46 PM EST - 1 year ago

CG Oncology valued at $1.75 bln in strong market debut


pat_soons_shlong
pat_soons_shlong Oct. 23 at 6:02 PM
$CGON what do you guys think of the current valuation? I just closed out of my position for a 55% gain, but id like to understand your guys perspective This is not my main stock and I don’t have the time for an intricate deep dive on more than a couple of my positions
0 · Reply
Buy_SoFi
Buy_SoFi Oct. 23 at 5:04 PM
$TLTFF $MRK $IBRX $CGON Potential NASDAQ listing rumored/expected? ---> $TLTFF
0 · Reply
Buy_SoFi
Buy_SoFi Oct. 23 at 5:03 PM
$TLTFF $MRK $IBRX $CGON NMIBC Phase II study about to complete enrolment. AMAZING numbers! (Potential FDA Accelerated Approval) ---> $TLTFF
0 · Reply
Jarra123
Jarra123 Oct. 10 at 3:11 PM
$CGON new competitor approaching with completed phase two, fast track for neoadjuvant therapy https://hamletbiopharma.com/hamlet-biopharma-announces-the-completion-of-the-alpha1h-phase-ii-study-in-non-muscle-invasive-bladder-cancer/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 10:56 PM
9/26/25 list results $CGAU $CGEN $CGNX $CGON 🔥 Cycle Trading Signal plugged into AI 🔥 list
0 · Reply
dlhman2002
dlhman2002 Oct. 9 at 2:05 PM
$CGON More large buys coming in today.
1 · Reply
autopilotcopytrader
autopilotcopytrader Oct. 8 at 3:50 PM
$CGON bought this morning premarket sold the rip yay :-) may reenter
0 · Reply
JarvisFlow
JarvisFlow Oct. 8 at 12:47 PM
Guggenheim has updated their rating for CG Oncology ( $CGON ) to Buy with a price target of 90.
0 · Reply
Grinding10
Grinding10 Oct. 7 at 5:48 PM
$CGON is this BLA ever going to get fucking submitted or what?
1 · Reply
Buy_SoFi
Buy_SoFi Sep. 23 at 3:00 PM
$TLTFF Rutherin and Ruvidar are miracle compounds, making other compounds even more potent. Acquisition target in the coming 2-3 years, maybe sooner. $CGON $IBRX
0 · Reply
Grinding10
Grinding10 Sep. 22 at 7:36 PM
$CGON guess we r back to the bullshit where it fades everyday again
0 · Reply
Buy_SoFi
Buy_SoFi Sep. 22 at 5:22 PM
$TLTFF Rutherrin(R) Shown to Be 100 Times More Effective Than Radiation Alone in Preclinical Cancer Models $CGON $IBRX $MRK $JNJ https://theralase.com/theralase-to-present-groundbreaking-research-at-astro-2025/
2 · Reply
Mik21212
Mik21212 Sep. 19 at 7:30 PM
0 · Reply
theflynews
theflynews Sep. 19 at 3:21 PM
Biotech Alert: Searches spiking for these stocks today - $CGON - https://thefly.com/permalinks/entry.php/CGONid4200713?1758294347C38
0 · Reply
Grinding10
Grinding10 Sep. 19 at 2:51 PM
$CGON guess the drug stopped working
0 · Reply
RoundAssRousey
RoundAssRousey Sep. 19 at 1:15 PM
$CGON steadily moving higher. picked this up at $25 on a tip from a buddy. Trial data looks good , price action looks good . Lets keeo it going!
0 · Reply
theflynews
theflynews Sep. 18 at 4:07 PM
Biotech Alert: Searches spiking for these stocks today - $CGON - https://thefly.com/permalinks/entry.php/CGONid4200159?1758211035C38
0 · Reply
Grinding10
Grinding10 Sep. 18 at 8:27 AM
$CGON had a buyout a couple years ago; ISEE 3 months before FDA decision; No rumors no nothing but the stock was moving just like this for 2 weeks; 🤷‍♂️
0 · Reply
GMExAPE
GMExAPE Sep. 17 at 10:05 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here. Historic short squeeze coming - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $LU $CGON $CORT $WGS $KC
0 · Reply
JarvisFlow
JarvisFlow Sep. 17 at 6:00 PM
Morgan Stanley has adjusted their stance on CG Oncology ( $CGON ), setting the rating to Overweight with a target price of 56 → 79.
0 · Reply
theflynews
theflynews Sep. 17 at 3:49 PM
Biotech Alert: Searches spiking for these stocks today - $CGON - https://thefly.com/permalinks/entry.php/CGONid4199421?1758124081C38
0 · Reply
dlhman2002
dlhman2002 Sep. 16 at 6:34 PM
$CGON Bullish September....
0 · Reply